Square Pharmaceuticals PLC 2025 AR2
The report highlights Square Pharmaceuticals PLC's operational and financial performance for the fiscal year 2024-2025, during which the company maintained its leading position in Bangladesh's pharmaceutical sector. Standalone net revenue rose modestly to BDT 59.98 billion, while consolidated revenue grew by 8.83% to BDT 76.29 billion. On the sustainability front, the company aligned its disclosures with IFRS S1 and IFRS S2 standards, reporting Scope 1 emissions of 196,584 tCO2e and Scope 2 emissions of 54,957 tCO2e. Additionally, the company expanded its renewable energy capacity with 820 kW of on-grid solar panels and engaged in various community and environmental initiatives, including planting over 200,000 trees since 2018.
Company: Square Pharmaceuticals PLC
Sector: Health Care
Country: Bangladesh
Year: 2025
Type: AR2
Pages: 176
Square Pharmaceuticals PLC
Annual Report
The report highlights Square Pharmaceuticals PLC's operational and financial performance for the fiscal year 2024-2025, during which the company maintained its leading position in Bangladesh's pharmaceutical sector. Standalone net revenue rose modestly to BDT 59.98 billion, while consolidated revenue grew by 8.83% to BDT 76.29 billion. On the sustainability front, the company aligned its disclosures with IFRS S1 and IFRS S2 standards, reporting Scope 1 emissions of 196,584 tCO2e and Scope 2 emissions of 54,957 tCO2e. Additionally, the company expanded its renewable energy capacity with 820 kW of on-grid solar panels and engaged in various community and environmental initiatives, including planting over 200,000 trees since 2018.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jul 1, 2024 - Jun 30, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Women in Management
Employees